STOCK TITAN

BioLife Solutions (BLFS) Stock News, May 2023-Jan 2024

BLFS

BioLife Solutions develops and supplies cell processing tools and bioproduction products for the cell and gene therapy market and broader biopharma customers. Company news commonly covers financial results from continuing operations, demand for biopreservation media, and the role of its products in maintaining biologic material during collection, development, manufacturing, storage, distribution, and thawing.

Recurring updates also include product-portfolio expansion, supply agreements for cell and gene therapy manufacturing inputs, CellSeal vial systems, human platelet lysate products, cytokine and growth factor distribution, and research activity tied to biopreservation and cryopreservation technologies.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.16%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.86%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
earnings date
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.85%
Tags
management
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
earnings date
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.64%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.97%
Tags
earnings date

FAQ

What is the current stock price of BioLife Solutions (BLFS)?

BioLife Solutions (BLFS) last closed at $38.61.